Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis

American Journal of Neuroradiology

Volumn 24, Issue 1, 2003, Pages 68-74

  Li, Belinda S Y ^a   Regal, Juleiga ^a   Soher, Brian J ^b   Mannon, Lois J ^a   Grossman, Robert I ^a   Gonen, Oded ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; BRAIN RADIOGRAPHY; CASE REPORT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAPSE; REMISSION; REMYELINIZATION; SENILE PLAQUE; THREE DIMENSIONAL IMAGING;

ADULT; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; ENERGY METABOLISM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; STATISTICS;

EID: 0037243959     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Simon JH. Contrast-enhanced MR imaging in the evaluation of treatment response and prediction of outcome in multiple sclerosis. J Magn Reson Imag 1997;7:29-37
2. Grossman RI, McGowan JC. Perspectives on multiple sclerosis. AJNR Am J Neuroradiol 1998;19:1251-1265
3. McFarland HF, Barkhof F, Antel J, Miller DH. The role of MRI as a surrogate outcome measure in multiple sclerosis. Mult Scler 2002;8:40-51
4. Miki Y, Grossman RI, Udupa JK, et al. Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images: lack of correlation between changes in T2 lesion volume and clinical findings. Radiology 1999;213:395-399
5. Ciccarelli O, Brex PA, Thompson AJ, Miller DH. Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR. J Neurol 2002;249:18-24
6. Barkhof F, Karas GB, van Walderveen MA. T1 hypointensities and axonal loss. Neuroimaging Clin NAm 2000;10:739-752
7. Uhlenbrock D, Sehlen S. The value of T1-weighted images in the differentiation between MS, white matter lesions, and subcortical arteriosclerotic encephalopathy (SAE). Neuroradiology 1989;31:203-212
8. van Walderveen MA, Barkhof F, Hommes OR, et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 1995;45:1684-1690
9. Truyen L, van Waesberghe JH, van Walderveen MA, et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-1476
10. Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001;56:304-311
11. Hiehle JF Jr, Grossman RI, Ramer KN, Gonzalez-Scarano F, Cohen JA. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 1995;16:69-77
12. Loevner LA, Grossman RI, McGowan JC, Ramer KN, Cohen JA. Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. AJNR Am J Neuroradiol 1995;16:1473-1479
13. van Walderveen MA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282-1288
14. Simon JH, Lull J, Jacobs LD, et al. A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Neurology 2000;55:185-192
15. van Walderveen MA, Barkhof F, Pouwels PJ, van Schijndel RA, Polman CH, Castelijns JA. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann Neurol 1999;46:79-87
16. Brex PA, Parker GJ, Leary SM, et al. Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations. J Neurol Neurosurg Psychiatry 2000;68:627-632
17. Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, Bruck W. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 2001;49:793-796
18. Weinshenker BG. Natural history of multiple sclerosis. Ann Neurol 1994;36:S6-S11
19. Hu J, Javaid T, Arias-Mendoza F, Liu Z, McNamara R, Brown TR. A fast, reliable, automatic shimming procedure using 1H chemicalshift-imaging spectroscopy. J Magn Reson B 1995; 108:213-219
20. Gonen O, Murdoch JB, Stoyanova R, Goelman G. 3D multivoxel proton spectroscopy of human brain using a hybrid of 8th-order Hadamard encoding with 2D chemical shift imaging. Magn Reson Med 1998;39:34-40
21. Kreis R, Ernst T, Ross BD. Absolute concentrations of water and metabolites in the human brain: II. metabolite concentrations. J Magn Reson 1993;102:9-19
22. Soher BJ, van Zijl PC, Duyn JH, Barker PB. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996;35:356-363
23. Marion D, Ikura M, Bax A. Improved solvent suppression in one-and two-dimensional NMR spectra by convolution of time domain data. J Magn Reson 1989;84:425-430
24. Campbell ID, Dobson CM, Williams RJ, Xavier ZV. Resolution enhancement of protein PMR spectra using the difference between a broadened and normal spectrum. J Magn Reson 1973;11:172-181
25. Vigneron DB, Nelson SJ, Murphy-Boesch J, et al. Chemical shift imaging of human brain: axial, sagittal, and coronal P-31 metabolite images. Radiology 1990;177:643-649
26. Soher BJ, Young K, Govindaraju V, Maudsley AA. Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 1998;40:822-831
27. 1H MR spectra. Magn Reson Med 2001;45: 966-972
28. Henriksen O. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS. NMR Biomed 1995;8:139-148
29. Christiansen P, Larsson HB, Henriksen O. Time dependence of N-acetylaspartate and choline containing compounds in multiple sclerosis. In: Proceedings of the Meeting of the Society of Magnetic Resonance in Medicine. vol 1. New York: 1993:279-279
30. Christiansen P, Toft P, Larsson HB, Stubgaard M, Henriksen O. The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn Reson Imaging 1993;11:799-806
31. van Waesberghe JH, van Walderveen MA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 1998;19:675-683
32. Li BS, Babb JS, Soher BJ, Maudsley AA, Gonen O. Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 2002;47:439-446
33. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58
34. Lassmann H, Bruck W, Lucchinetti C, Rodriguez M. Remyelination in multiple sclerosis. Mult Scler 1997;3:133-136
35. Miller BL. A review of chemical issues in IH NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4: 47-52
36. Mader I, Roser W, Kappos L, et al. Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study. AJNR Am J Neuroradiol 2000;21:1220-1227
37. McIlwain H, Bachelard H.S. Biochemistry and the Central Nervous System. Edinburgh: Churchill Livingstone; 1985
38. Arnold DL, Matthews PM, Francis GS, O'Connor J, Antel JP. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992;31: 235-241
39. Husted CA, Goodin DS, Hugg JW, et al. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and IH spectroscopic imaging Ann Neurol 1994;36:157-165
40. Brenner RE, Munro PM, Williams SC, et al. The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 1993;29:737-745
41. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neuroscience 1993;13:981-989
42. van Waesberghe JH, Kamphorst W, De Groot CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747-754
43. Barkhof F, van Walderveen M. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance. Philos Trans R Soc Lond B Biol Sci 1999;354:1675-1686
44. Arnold DL, Wolinsky JS, Matthews PM, Falini A. The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;94 S1:S94-S101
45. De Stefano N, Narayanan S, Pelletier D, Francis GS, Antel JP, Arnold DL. Evidence of early axonal damage in patients with multiple sclerosis. Neurology 1999;52:A378-A378
46. De Stefano N, Narayanan S, Francis GS, et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001;58:65-70